Product Information

WARFARIN SODIUM 4 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1005 per EA under NDC 00093171610. Its NADAC has been published 583 times since Sep 16, 2015.

FDA first approved this application on Jul 5, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

WARFARIN SODIUM 4 MG TABLET

Warfarin Sodium
$0.1005per EA

Strength

4 mg/1

NDC

00093171610

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

WARFARIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA040616

FDA Approved

7/5/2006

TE Code

AB

On Market Since

6/9/2015

Pharmacological Classes

Vitamin K Antagonist
Vitamin K Inhibitors

Price Statistics

The NADAC for WARFARIN SODIUM 4 MG TABLET has been published 583 times since Sep 16, 2015, and over the history we have for it it has declined 46.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1005 per EA
All-time high$0.1975 (Oct 14, 2015)
All-time low$0.0770 (Jul 17, 2024)
52-week high$0.1005
52-week low$0.0782
Median price$0.1041
Average price$0.1103
Largest weekly change+30.6% (Nov 23, 2022)
Weeks tracked583
Tracking sinceSep 16, 2015

Price History

1W

0.0%

1M

+5.1%

3M

+3.8%

6M

+12.7%

1Y

+12.5%

3Y

+10.9%

5Y

+11.3%

All

-46.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of WARFARIN SODIUM 4 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for WARFARIN SODIUM 4 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1005 per EA (NDC 00093171610), effective Nov 11, 2026.

How has the price of WARFARIN SODIUM 4 MG TABLET changed over time?

Over the history we have for it, the NADAC for WARFARIN SODIUM 4 MG TABLET has declined 46.1%. It has been tracked across 583 weekly CMS publications since Sep 16, 2015.

What are the highest and lowest recorded NADAC prices for WARFARIN SODIUM 4 MG TABLET?

Since Sep 16, 2015, the NADAC for WARFARIN SODIUM 4 MG TABLET has ranged from a low of $0.0770 (Jul 17, 2024) to a high of $0.1975 (Oct 14, 2015), with a median of $0.1041 per EA.

Are there cheaper alternatives to WARFARIN SODIUM 4 MG TABLET?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, JANTOVEN 4 MG TABLET, is $0.0892 per EA — about 11% below WARFARIN SODIUM 4 MG TABLET.

Who manufactures WARFARIN SODIUM 4 MG TABLET?

WARFARIN SODIUM 4 MG TABLET (NDC 00093171610) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.